These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9772443)

  • 1. [Current status of chemotherapy of breast cancer].
    Song S
    Zhonghua Yi Xue Za Zhi; 1997 Jul; 77(7):484-5. PubMed ID: 9772443
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neoadjuvant systemic chemotherapy for patients with operable breast cancer].
    Zhang B; Zhang Q
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):161-5. PubMed ID: 17649628
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized Trial.
    Ferretti G; Felici A; Carlini P; Cognetti F
    J Natl Cancer Inst; 2007 Sep; 99(18):1416. PubMed ID: 17848675
    [No Abstract]   [Full Text] [Related]  

  • 4. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
    Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
    Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quality outcome of adjuvant CMF therapy in patients with breast cancer].
    Kleeberg UR
    Strahlenther Onkol; 2000 Jun; 176(6):290-1. PubMed ID: 10897257
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant therapy for breast cancer: we are solving the puzzle, but pieces are still missing.
    Pritchard KI
    J Natl Cancer Inst; 2007 Apr; 99(7):494-5. PubMed ID: 17405988
    [No Abstract]   [Full Text] [Related]  

  • 7. Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer.
    Bonadonna G; Valagussa P; Veronesi U
    J Clin Oncol; 2008 Jan; 26(3):342-4. PubMed ID: 18202404
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of smoking history on breast cancer prognosis: retrospective study of 240 operable breast cancer patients who received adjuvant cyclophosphamide, doxorubicin, and 5-fluorouracil chemotherapy regimen.
    Aksoy S; Harputluoglu H; Guler N; Altundag K; Hayran M; Tekuzman G; Ozisik Y
    Breast J; 2007; 13(4):431-2. PubMed ID: 17593056
    [No Abstract]   [Full Text] [Related]  

  • 9. Life after adjuvant chemotherapy for breast cancer: the news is mostly good.
    Kiely BE; Wilcken NR; Stockler MR
    J Clin Oncol; 2011 Mar; 29(9):1092-3. PubMed ID: 21300925
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preoperative chemotherapy in breast cancer and the development of new predictive markers].
    Denkert C; Schickling O; von Minckwitz G
    Verh Dtsch Ges Pathol; 2006; 90():114-23. PubMed ID: 17867587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin as an addition to conventional chemotherapy in breast cancer.
    Grenader T; Goldberg A; Shavit L
    J Clin Oncol; 2009 Dec; 27(35):e259; author reply e260. PubMed ID: 19884518
    [No Abstract]   [Full Text] [Related]  

  • 12. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
    Tamura K
    Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
    [No Abstract]   [Full Text] [Related]  

  • 13. Revised prognostic table to guide practitioners advising patients on adjuvant systematic therapy in early breast cancer.
    Stotter A
    Eur J Surg Oncol; 2007 Dec; 33(10):1211-2. PubMed ID: 17399937
    [No Abstract]   [Full Text] [Related]  

  • 14. [The evaluation of therapeutic results as exemplified by the adjuvant chemotherapy of breast carcinoma].
    von Heyden HW
    Dtsch Med Wochenschr; 2000 Mar; 125(11):340. PubMed ID: 10761479
    [No Abstract]   [Full Text] [Related]  

  • 15. [Taxanes in neojuvant radio-, chemoradio- and chemotherapy for breast cancer].
    Bozhok AA; Semiglazov VF; Kletzel' AE; Arzumanov AS; Mel'nikova OA; Paltuev RM; Ivanova OA; Semiglazov VV
    Vopr Onkol; 2006; 52(1):7-14. PubMed ID: 16715697
    [No Abstract]   [Full Text] [Related]  

  • 16. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.
    Adjuvant Breast Cancer Trials Collaborative Group
    J Natl Cancer Inst; 2007 Apr; 99(7):506-15. PubMed ID: 17405995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible ovarian ablation or chemotherapy: are we ready for quality of life to guide adjuvant treatment decisions in breast cancer?
    Goodwin PJ
    J Clin Oncol; 2003 Dec; 21(24):4474-5. PubMed ID: 14610047
    [No Abstract]   [Full Text] [Related]  

  • 18. Can endocrine treatment for hormone-positive premenopausal women with early breast cancer replace adjuvant chemotherapy?
    Malayeri R
    J Clin Oncol; 2003 Jun; 21(12):2444-5; author reply 2446-7. PubMed ID: 12805348
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant systemic therapy for early breast cancer: progress and controversies.
    Hortobagyi GN
    Clin Cancer Res; 2001 Jul; 7(7):1839-42. PubMed ID: 11448893
    [No Abstract]   [Full Text] [Related]  

  • 20. [Toxicity of doxorubicin and cyclophosphamide (60 mg/600 mg/m2) in adjuvant chemotherapy for breast cancer].
    Tsutani Y; Saeki T; Aogi K; Ohsumi S; Takashima S
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):809-13. PubMed ID: 15984521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.